Wall Street News, AI generated

latest news in Biotechnology

CASI Pharmaceuticals Secures New Capital to Advance Key Medical Research

CASI Pharmaceuticals Secures New Capital to Advance Key Medical Research

Rockville, Friday, 14 August 2026.
CASI Pharmaceuticals reported $9.8 million in first-half revenue while securing $15 million in new funding and a major legal victory to advance its lead drug trials.

Ensysce Biosciences Expands Pain Treatment Pipeline with Strategic Acquisition

Ensysce Biosciences Expands Pain Treatment Pipeline with Strategic Acquisition

San Diego, Thursday, 13 August 2026.
Ensysce Biosciences completed its acquisition of Cy Biopharma, securing up to $77 million in potential funding and adding an Orphan Drug-designated pain candidate to advance into Phase 2 trials.

Ionis Reports Strategic Q2 Operating Loss as Commercial Pipeline Expansion Accelerates

Ionis Reports Strategic Q2 Operating Loss as Commercial Pipeline Expansion Accelerates

Carlsbad, Sunday, 9 August 2026.
Ionis Pharmaceuticals logged a $102 million Q2 operating loss while advancing key therapies, highlighted by TRYNGOLZA’s landmark FDA approval that targets a $3 billion peak market.